News
Home News

Warning: strtotime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /var/www/vhosts/veritastherapeutics.com/httpdocs/news/details.php on line 73

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /var/www/vhosts/veritastherapeutics.com/httpdocs/news/details.php on line 73
17 Apr 2012
A new grant to validate FGL2-based technologies

Veritas receives an operating grant to validate FGL2-based technologies for treatment of chronic viral infections. The study will confirm the utility of FGL2 technologies in patients with chronic viral infections. The results of these clinical studies will have broader implications for other immune-mediated disease including autoimmunity, transplant rejection and cancer.